There is hardly another product that reaches consumers or patients for which packaging requirements are as varied as for pharmaceutical products.
The »Poisons Prevention Packaging Act« (PPPA) enacted in the United States back in 1970 addresses the issue of child-resistant packaging of substances that are potentially harmful to human health. In the EU, DIN EN ISO 8317 and DIN EN 14375 standards set out the requirements for child-resistant packaging. In the light of these demands, it is surprising that hardly any packs containing medicines are currently provided with tamper- proof seals. The implementation of the EU’s “Falsified Medicines Directive” intends to change this.
For more details, download White Paper here: